These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21393964)

  • 21. Acute graft-versus-host disease (GVHD) overlapping chronic GVHD after reinduction chemotherapy.
    Delgado-Jimenez Y; Goiriz R; Vargas-Diez E; Fraga J; Garcia-Diez A; Fernandez-Herrera J
    Br J Dermatol; 2007 Feb; 156(2):388-90. PubMed ID: 17223891
    [No Abstract]   [Full Text] [Related]  

  • 22. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia.
    Niederwieser D; Pepe M; Storb R; Witherspoon R; Longton G; Sullivan K
    Bone Marrow Transplant; 1989 Mar; 4(2):151-6. PubMed ID: 2650784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
    [No Abstract]   [Full Text] [Related]  

  • 25. Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis.
    Romagnani P; Lazzeri E; Mazzinghi B; Lasagni L; Guidi S; Bosi A; Cirami C; Salvadori M
    Am J Kidney Dis; 2005 Sep; 46(3):550-6. PubMed ID: 16129218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic peripheral blood stem cell transplantation in aplastic anemia.
    Damodar S; Murthy S
    Indian Pediatr; 2006 Jan; 43(1):82-3. PubMed ID: 16465020
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
    Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
    Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamic monitoring of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation by soluble HLA-I antigen detection].
    Xia R; Qiu HY; Zhang WP; Cao Q; Lan JC; Wen HS; Wang JM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):687-90, 695. PubMed ID: 15958310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab responsive refractory acute graft-versus-host disease.
    Kamble R; Oholendt M; Carrum G
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1201-2. PubMed ID: 17085314
    [No Abstract]   [Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
    Koh LP; Koh MB; Ng HY; Hwang WY; Goh YT; Linn YC; Ng HJ; Chuah CT; Tan KW; Loh YS; Tan DC; Tan PH; Tan PH
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):887-90. PubMed ID: 16864060
    [No Abstract]   [Full Text] [Related]  

  • 32. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
    Ivanov V; Faucher C; Bilger K; Vey N; Sainty D; Calmels B; Chabannon C; Lafage-Pochitaloff M; Mozziconacci MJ; Mohty M; Chrestian MA; Blaise D
    Bone Marrow Transplant; 2003 Nov; 32(9):961-3. PubMed ID: 14562000
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.
    Lazarus HM; Sommers SR; Arfons LM; Fu P; Ataergin SA; Kaye NM; Liu F; Kindwall-Keller TL; Cooper BW; Laughlin MJ; Creger RJ; Barr PM; Gerson SL; Kaplan D
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):970-8. PubMed ID: 21440080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unmanipulated haploidentical peripheral blood stem cell transplantation for precursor T-cell lymphoblastic lymphoma relapsed after autologous PBSCT.
    Zhou Y; Huang W; Li H; Yu L
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):224-6. PubMed ID: 21336164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic graft versus host disease after allogeneic peripheral blood transplantation.
    Urbano-Ispìzua A
    Haematologica; 2003 Mar; 88(3):245-6. PubMed ID: 12651259
    [No Abstract]   [Full Text] [Related]  

  • 38. [The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):86-9. PubMed ID: 12697103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of patients who received transplants for aplastic anemia or leukemia.
    Gluckman E; Devergie A; Meletis J; De Castro H; Lehn P; Bourrhis JH; Keable H; Cavazzana M; Varrin F; Bombail D
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2643. PubMed ID: 3274572
    [No Abstract]   [Full Text] [Related]  

  • 40. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution.
    de la Rubia J; Cantero S; Sanz GF; Remigia MJ; Monteagudo E; Moscardó F; Martín G; Lorenzo I; Jiménez C; Martínez J; Montesinos P; Jarque I; Sanz MA
    Bone Marrow Transplant; 2005 Aug; 36(4):325-9. PubMed ID: 15968276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.